|
Diabetes, Vol 44, Issue 11 1318-1322, Copyright © 1995 by American Diabetes Association
Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients
M Trovati, EM Mularoni, S Burzacca, MC Ponziani, P Massucco, L Mattiello, V Piretto, F Cavalot and G Anfossi
Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
To investigate the effects of insulin on platelets in obesity and in
non-insulin-dependent diabetes mellitus (NIDDM)--classic insulin-resistant
states--we determined ADP-induced platelet aggregation and platelet cGMP
(guanosine 3',5'-cyclic monophosphate) content in platelet-rich plasma
obtained from nine obese subjects and nine age-matched healthy volunteers
and from eight NIDDM obese patients and nine age-matched healthy volunteers
after a 3-min incubation with human recombinant insulin (0, 240, 480, 960,
and 1,920 pmol/l). Platelet aggregation was evaluated using different ADP
doses to measure the ADP concentration determined on the basis of a
dose-response curve necessary to elicit a maximal aggregation of 50%
(ED50). Insulin induced a dose-dependent decrease of platelet aggregation
to ADP (P = 0.0001) in healthy subjects. A significant effect was evident
starting from an insulin concentration of 240 pmol/l. On the contrary, in
insulin-resistant subjects, insulin reduced platelet sensitivity to ADP
only at a concentration of 1,920 pmol/l. When ADP ED50 values obtained in
platelet-rich plasma incubated with insulin were expressed in percentage of
the ADP ED50 values obtained in platelet-rich plasma without insulin,
considered as 100%, we observed that ADP ED50 with 1,920 pmol/l insulin was
153.6 +/- 13.2% in the younger healthy subject group (P = 0.004), 150.0 +/-
3.8% in the older healthy subject group (P = 0.0001), 116.1 +/- 6.1% in
obese subjects (P = 0.031), and 120.0 +/- 8.6% in NIDDM patients (P =
0.05). In healthy subjects, insulin induced a dose-dependent increase of
platelet cGMP (P = 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Russo, P. Del Mese, G. Doronzo, A. De Salve, M. Secchi, M. Trovati, and G. Anfossi
Platelet Resistance to the Antiaggregatory Cyclic Nucleotides in Central Obesity Involves Reduced Phosphorylation of Vasodilator-Stimulated Phosphoprotein
Clin. Chem.,
June 1, 2007;
53(6):
1053 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dentali, E. Romualdi, and W. Ageno
The metabolic syndrome and the risk of thrombosis
Haematologica,
March 1, 2007;
92(3):
297 - 299.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basili, G. Pacini, M. T. Guagnano, M. R. Manigrasso, F. Santilli, C. Pettinella, G. Ciabattoni, C. Patrono, and G. Davi
Insulin Resistance as a Determinant of Platelet Activation in Obese Women
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2531 - 2538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Endocr. Rev.,
February 1, 2004;
25(1):
153 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, et al.
HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects: Prospective data from the Verona Diabetes Complications Study
Diabetes Care,
July 1, 2002;
25(7):
1135 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Westerbacka, H. Yki-Jarvinen, A. Turpeinen, A. Rissanen, S. Vehkavaara, M. Syrjala, and R. Lassila
Inhibition of Platelet-Collagen Interaction: An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2002;
22(1):
167 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Vinik, T. Erbas, T. S. Park, R. Nolan, and G. L. Pittenger
Platelet Dysfunction in Type 2 Diabetes
Diabetes Care,
August 1, 2001;
24(8):
1476 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Westerbacka, I. Wilkinson, J. Cockcroft, T. Utriainen, S. Vehkavaara, and H. Yki-Jarvinen
Diminished Wave Reflection in the Aorta : A Novel Physiological Action of Insulin on Large Blood Vessels
Hypertension,
May 1, 1999;
33(5):
1118 - 1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bonora, J. Willeit, S. Kiechl, F. Oberhollenzer, G. Egger, R. Bonadonna, and M. Muggeo
Relationship Between Insulin and Carotid Atherosclerosis in the General Population : The Bruneck Study
Stroke,
June 1, 1997;
28(6):
1147 - 1152.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|